{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:14:57Z","timestamp":1779916497374,"version":"3.53.1"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    We present a 54-year-old woman with chronic kidney disease, hypercalcemia, and hyperparathyroidism, who exhibited multiple osteolytic lesions and a suspicious parathyroid adenoma.\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG PET\/CT revealed increased metabolic activity in the lytic lesions, raising suspicion for multiple myeloma or brown tumors. A biopsy confirmed brown tumors. Subsequent\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Trivehexin PET\/CT showed intense \u03b1v\u03b26-integrin expression in the parathyroid adenoma and moderate uptake in the brown tumors. This highlights the potential utility of\n                    <jats:sup>68<\/jats:sup>\n                    Ga-Trivehexin in the characterization of osteolytic lesions in hyperparathyroidism.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000005989","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:00:38Z","timestamp":1747738838000},"page":"e46-e47","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["68Ga-Trivehexin Uptake in Brown Tumors in Hyperparathyroidism"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6173-679X","authenticated-orcid":false,"given":"Siven","family":"Kar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram R.","family":"Lele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusrat","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"R1-20251210","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s00259-021-05559-x","article-title":"PET\/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the \u201cCancer Integrin\u201d \u03b1v\u03b26 with Ga-68-Trivehexin","volume":"49","author":"Quigley","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"suppl 2","key":"R2-20251210","first-page":"242021","article-title":"Immunohistochemical validation and efficacy of 68Ga-Trivehexin PET CT as molecular imaging agent for \u00ce\u00b1v\u00ce26 integrin expression in patients of head and neck squamous cell carcinoma and pancreatic ductal adenocarcinoma","volume":"65","author":"Das","year":"2024","journal-title":"J Nucl Med"},{"issue":"suppl 2","key":"R3-20251210","first-page":"242550","article-title":"Initial experience of 68Ga-Trivehexin PET-CT in follow-up cases of head and neck squamous cell carcinoma (HNSCC) and head-to-head comparison with 18F-FDG PET-CT","volume":"65","author":"Vindhya","year":"2024","journal-title":"J Nucl Med"},{"key":"R4-20251210","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1007\/s00259-024-06846-z","article-title":"68Ga-Trivehexin PET\/CT: a promising novel tracer for primary hyperparathyroidism","volume":"51","author":"Kuyumcu","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20251210","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1158\/1541-7786.MCR-08-0568","article-title":"Parathyroid hormone-related protein regulates cell survival pathways via integrin \u03b16\u03b24-mediated activation of PI3-K\/Akt signaling","volume":"7","author":"Bhatia","year":"2009","journal-title":"Mol Cancer Res"},{"key":"R6-20251210","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000444703","article-title":"Brown tumors: a case report and review of the literature","volume":"6","author":"Can","year":"2016","journal-title":"Case Rep Nephrol Dial"},{"key":"R7-20251210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s41824-023-00168-3","article-title":"Widespread presentation of brown tumors mimicking multiple myeloma","volume":"7","author":"Duyck","year":"2023","journal-title":"Eur J Hybrid Imaging"},{"key":"R8-20251210","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jbspin.2016.06.007","article-title":"Contribution of 18-FDG PET\/CT to brown tumor detection in a patient with primary hyperparathyroidism","volume":"84","author":"Gahier Penhoat","year":"2017","journal-title":"Joint Bone Spine"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:00:27Z","timestamp":1765371627000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005989"}},"subtitle":["A Novel Finding"],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005989","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"2025-01-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}